Hospital-at-Home Reduces In-Hospital Mortality, ED Visits – But Not Readmissions

Why It Matters

HaH delivers comparable or better short‑term outcomes at similar cost, offering a scalable solution to hospital capacity constraints and rising health‑care expenditures.

Key Takeaways

• Hospital-at-home cut in-hospital mortality to 0.4% vs 3.6%
• ED visits dropped to 8.8% from 10% for home patients
• Readmission rates unchanged, about 11% for both groups
• ICU escalation halved, 3.5% vs 7.9% in traditional care

Pulse Analysis

Hospital‑at‑home programs have accelerated in the United States after the Medicare waiver expanded telehealth and remote monitoring capabilities. By delivering acute care in a patient’s residence, hospitals can free up beds, reduce staffing pressures, and potentially lower costs. Early adopters in the Northeast and South have demonstrated that, with proper patient selection, the model can meet regulatory standards while preserving the quality of care expected from inpatient settings.

The JAMA Network Open analysis of 4,200 HaH admissions versus 11,700 traditional stays provides the most robust evidence to date. Mortality fell dramatically—from 3.6% in the hospital to just 0.4% at home—suggesting that rapid escalation protocols and intensive home‑based monitoring can match or exceed inpatient safety nets. Emergency‑department utilization also declined, and ICU transfers were cut by more than half. However, readmission rates hovered around 11% for both cohorts, indicating that while acute episodes are managed effectively at home, post‑discharge continuity remains a challenge. Overall 30‑day spending was modestly lower, reinforcing the economic case for broader HaH deployment.

For health‑system leaders, the findings underscore a strategic opportunity: integrate HaH into care pathways for clinically appropriate patients to alleviate bed shortages and improve outcomes. Yet scaling will require addressing uneven geographic adoption, reimbursement certainty, and workforce training to ensure equitable access. As policymakers consider making the temporary waiver permanent, the evidence suggests that a well‑designed HaH framework could become a cornerstone of value‑based care, reshaping how acute services are delivered across the nation.